To develop a signature for prognosis prediction of BLCA, 19 genes (C1QTNF6, DAB2, ESD, FKBP10, GAD1, INHBA, LAMA2, LGALS3, MPPED1, OLFML3, PCOLCE, RASD1, RGS12, RUNX2, TIMP2, TMEM151A, TSSK1B, VAT1, and VEGFA) were obtained to build the risk model (Figures 3A, B). The gene discussed is RGS12; the disease is bladder transitional cell carcinoma.